| Issue |
Title |
| Vol 7, No 2 (2014) |
Glaucoma and the dry eye syndrome |
|
|
Brjesky V.V., Radukhan M. |
| "... The development of the dry eye syndrome in glaucoma patients is a pressing challenge during last 10 ..." |
| Vol 9, No 2 (2016) |
Taflotan, the first preservative-free prostaglandin F2α analogue: treatment advantages in primary open-angle glaucoma patients |
|
|
Astakhov S.Y., Tkachenko N.V. |
| "... Over the past 15 years, the negative role of toxic preservatives in the IOP-lowering eye drops ..." |
| Vol 10, No 2 (2017) |
Analysis of treatment results in dry eye syndrome patients after phacoemulsification by preservative-free 0.3% sodium hyaluronate eye drops |
|
|
Pirogov Y.I., Butina G.M., Oksentjuk A.A., Khromova E.S. |
| "... Postsurgical dry eye syndrome is found in a substantial proportion of patients after ..." |
| Vol 9, No 1 (2016) |
Use of the drug in patients tealoz primary open angle glaucoma syndrome "dry eye" |
|
|
Ushakova L.I., Balalin S.V. |
| "... Dry eye syndrome is frequently observed in patients with primary open-angle glaucoma with prolonged ..." |
| Vol 7, No 4 (2014) |
The experience of “Hyloparin” use in clinical practice |
|
|
Tkachenko N.V., Astakhov S.Y. |
| "... The incidence of the “dry eye” syndrome diagnosis in developed countries increases from year ..." |
| Vol 8, No 1 (2015) |
Pharmacoeconomic aspects of glaucoma therapy with prostaglandin analogues in patients with signs of ocular surface disease |
|
|
Rudakova A.V. |
| "... . The costs of glaucoma treatment with preservative-free tafluprost and with branded BAK-preserved latanoprost ..." |
| Vol 9, No 4 (2016) |
Trehalose efficacy in dry eye syndrome treatment after phacoemulsification |
|
|
Astakhov S.Y., Tkachenko N.V. |
| "... Purpose to estimate the efficacy of “artificial tear” preparation on the trehalose base in dry eye ..." |
| Vol 11, No 1 (2018) |
Investigation of tear production dynamics in patients with age-related cataract before and after phacoemulsification |
|
|
Tonkonogiy S.V., Bai L.U., Vasilyev A.V. |
| "... with initial low TP indices have potentially high risk of developing clinically significant dry eye syndrome. ..." |
| Vol 10, No 3 (2017) |
A new method for treatment severe forms of dry keratoconjunctivitis (preliminary results) |
|
|
Safonova T.N., Gladkova O.V., Novikov I.A., Boev V.I. |
| "... Цель — усовершенствование способа лечения тяжёлых форм сухого кератоконъюнктивита (СКК) на основе ..." |
| Vol 9, No 2 (2016) |
Trehalose efficacy in dry eye syndrome therapy in diabetic patients |
|
|
Grigorieva N.N., Peich M.E., Shadrichev F.E. |
| "... The prevalence of diabetes mellitus with ocular involvement and that of dry eye syndrome constantly ..." |
| Vol 7, No 1 (2014) |
The evolution of tear substitutes: from saline solutions to cationic nanoemulsion |
|
|
Vokhmyakov A.V. |
| "... слова: синдром «сухого глаза»; слёзозаменители; катионная эмульсия; нанотехнологии.
Представительство ..." |
| Vol 9, No 3 (2016) |
Efficacy of 0.01% dexamethasone solution in comprehensive therapy of dry eye disease |
|
|
Brzheskiy V.V., Popov V.Y., Kalinina I.V., Kalinina N.M., Chenenova L.V. |
| "... antiinflammatory effect. But the widespread use of this dose in the management of dry eye diseases is limited ..." |
| Vol 10, No 4 (2017) |
Experience in Gilan Comfort eye drops use of in patients after excimer laser surgery |
|
|
Astakhov S.Y., Riks I.A. |
| "... The article presents treatment results of the dry eye syndrome after excimer laser refractive ..." |
| Vol 9, No 1 (2016) |
Use of Restasis (cyclosporine) in patients with dry eye syndrome |
|
|
Butin E.V., Florentseva S.S., Veselov A.V., Morozov M.A. |
| "... Dry eye syndrome produces an inflammatory process of autoimmune origin. Thus, the use ..." |
| Vol 7, No 1 (2014) |
Neurotrophic corneal and conjunctival xerosis |
|
|
Zhurova S.G. |
| "... patients (86 eyes) with severe dry eye syndrome complicated by xerotic corneal ulcers were examined. In all ..." |
| Vol 7, No 3 (2014) |
Current trends in the therapy of the ocular surface epithelial xerosis |
|
|
Brzheskaya I.V., Brjesky V.V., Radukhan M. |
| "... Depending on the cause of a “dry eye” the treatment of some patients continues to be a problem ..." |
| Vol 8, No 2 (2015) |
Our experience of Restasis® use in patients with “dry eye” syndrome occurring against the context of graft versus host reaction after bone marrow allografting |
|
|
Astakhov S.Y., Tkachenko N.V., Chistyakova N.V. |
| "... . Согласно инструкции, показанием к его назначению является «сухой» кератоконъюнктивит со сниженной ..." |
| Vol 10, No 1 (2017) |
Prostaglandin analogues: past, present, and future |
|
|
Astakhov Y.S., Nechiporenko P.A. |
| "... -analyzes, as well as modern trends in the topical IOP-lowering glaucoma therapy evolution. ..." |
| Vol 10, No 3 (2017) |
Experience in the Cationorm® use in the treatment of dry eye syndrome in patients after adenoviral keratoconjunctivitis |
|
|
Sokolov V.O., Morozova N.V., Polovinkina G.V., Borisova M.L., Zvontsova I.N., Gasymzade L.M., Kulikova Y.A., Shtupun D.R., Batynkova O.S. |
| "... The dry eye syndrome ranges among widespread and persisting ophthalmic diseases. It is also called ..." |
| Vol 6, No 2 (2013) |
Heidelberg Cornea Tomography usein assessment of Cyclosporin A treatmentresults in patients with “dry eye “ syndrome |
|
|
Florentseva S.S., Veselov A.V., Butin Y.V., Morozova N.V. |
| "... «сухОгО глаза»
препаратОм циклОспОрин а («рестасис»)
© С.С. Флоренцева, А.В. Веселов, Е.В. Бутин, Н ..." |
| Vol 6, No 4 (2013) |
The tolerability and clinical efficacy of “OKOMISTIN” in combination with “Oftalmoferon” in comparison to “Oftalmoferon” as monotherapy in the treatment of adenoviral eye diseases |
|
|
Astakhov Y.S., Sokolov V.O., Morozova N.V., Borisov D.A., Polovinkina G.V., Golikova Y.L., Botova N.V. |
| "... ; «Офтальмоферон»; «Окомистин»;
противовирусная терапия; синдром «сухого глаза».
1 Кафедра офтальмологии с ..." |
| Vol 6, No 1 (2013) |
Primenenie preparata Restasis® (RESTASIS®, tsiklosporin 0,05%) — glaznye kapli dlya lecheniya postgerpeticheskogo simblefarona |
|
|
Borisov D.A. |
| "... ; синдром сухого глаза; герпетический кератоконъюнктивит.
© Д. А. Борисов
Диагностический центр № 7 ..." |
| Vol 6, No 2 (2013) |
An experience of Retinalamin use in glaucomatous optic neuropethy and age-related macular degeneration |
|
|
Astakhov Y.S., Butin Y.V., Morozova N.V., Sokolov V.O., Florentseva S.S. |
| "... using objective investigation methods in patients with primary open-angle glaucoma stage 1 and 2 ..." |
| Vol 10, No 1 (2017) |
Confocal microscopy in ocular surface disease |
|
|
Potemkin V.V., Varganova T.S., Ageeva E.V. |
| "... in patients with dry eye, and propose our examination algorithm of ocular surface investigation in dry eye ..." |
| Vol 10, No 1 (2017) |
Comparison of cytotoxicity of fluoroquinolone antimicrobial eye drops and its effect on their bioavailability |
|
|
Hintuba T.S., Takhtaev Y.V., Okolov I.N., Motyleva V.A., Shlyakman R.B. |
| "... eye drops, registered in the Russian Federation: 1) Oftaquix™ (levofloxacin 5 mg/ml; preservative ..." |
| 1 - 25 of 128 Items |
1 2 3 4 5 6 > >> |
